Literature DB >> 28168924

Development of a new nomogram to predict insignificant prostate cancer in patients undergoing radical prostatectomy.

Tae Heon Kim1, Hwang Gyun Jeon2, Byong Chang Jeong2, Seong Il Seo2, Seong Soo Jeon2, Han Yong Choi2, Hyun Moo Lee2.   

Abstract

OBJECTIVE: The aim of this study was to develop a nomogram to predict the probability of insignificant prostate cancer.
MATERIALS AND METHODS: A retrospective analysis was conducted of patients who underwent radical prostatectomy at a Korean hospital between January 2005 and December 2014. Patients with pathologically insignificant prostate cancer were defined as having organ-confined disease with tumor volume less than 0.5 cm³ without Gleason scores of 4 or 5. Multivariable logistic regression analysis with a stepwise selection was used to model the relationship between preoperative characteristics and insignificant prostate cancer, and a nomogram to predict the probability of insignificant prostate cancer was created. Receiver operating characteristics (ROC) analysis was performed to assess the predictive value of the model.
RESULTS: The final study population consisted of 1343 patients. Among these patients, insignificant prostate cancer was confirmed in 188 men (14.0%) at the time of prostatectomy. Six independent predictors of insignificant prostate cancer were identified: number of positive cores (p < 0.001), maximal single core tumor involvement (p < 0.001), biopsy Gleason score (p < 0.001), prostate volume (p = 0.024), patient age (p < 0.001) and prostate-specific antigen density (p < 0.001) in the multivariable model. A nomogram to predict insignificant prostate cancer was developed using these six preoperative characteristics. The area under the ROC curve for nomogram predictions was 0.87.
CONCLUSION: The nomogram developed in this paper identifies the probability of insignificant prostate cancer and gives providers more information to guide their clinical decisions.

Entities:  

Keywords:  Insignificant; nomogram; prostatectomy; prostatic neoplasm

Mesh:

Substances:

Year:  2017        PMID: 28168924     DOI: 10.1080/21681805.2016.1266384

Source DB:  PubMed          Journal:  Scand J Urol        ISSN: 2168-1805            Impact factor:   1.612


  5 in total

1.  Risk reduction in kidney surgery.

Authors:  Martin Marszalek
Journal:  Ann Transl Med       Date:  2019-07

2.  Development and validation of prognostic nomograms for patients with metastatic prostate cancer.

Authors:  Wei-Dong Jiang; Ping-Cheng Yuan
Journal:  Int Urol Nephrol       Date:  2019-07-09       Impact factor: 2.370

3.  The potential value of microRNA-145 for predicting prognosis in patients with ovarian cancer: A protocol for systematic review and meta-analysis.

Authors:  Zhen Chen; Zelan Xiao; Siheng Zeng; Zhiqiang Yan
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

4.  Development and validation of a preoperative nomogram for predicting survival of patients with locally advanced prostate cancer after radical prostatectomy.

Authors:  Xianghong Zhou; Qingyang Ning; Kun Jin; Tao Zhang; Xuelei Ma
Journal:  BMC Cancer       Date:  2020-02-04       Impact factor: 4.430

5.  Metabolic characterization and pathway analysis of berberine protects against prostate cancer.

Authors:  Xianna Li; Aihua Zhang; Hui Sun; Zhidong Liu; Tianlei Zhang; Shi Qiu; Liang Liu; Xijun Wang
Journal:  Oncotarget       Date:  2017-04-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.